Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Goldencel Biotechnology Co., Ltd. is a specialized biotechnology enterprise focused on the research, development, and production of veterinary biological products. Headquartered in Shijiazhuang, Hebei Province, the company operates state-of-the-art GMP-certified manufacturing facilities dedicated to animal health. Its product portfolio primarily includes vaccines for livestock, targeting major diseases such as Classical Swine Fever, Pseudorabies, and Porcine Reproductive and Respiratory Syndrome. Goldencel utilizes advanced cell culture and virus purification technologies to ensure the efficacy and safety of its veterinary medicines. The company plays a significant role in the Chinese animal husbandry industry by providing essential preventive healthcare solutions for large-scale farming operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Goldencel Biotechnology.